Crsp zacks score
WebCRSP Complete CRISPR Therapeutics AG stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. ... Apr. 4, 2024 at 12:43 p.m. ET on Zacks.com. CRISPR ... WebApr 14, 2024 · CRISPR Therapeutics AG (CRSP Quick Quote CRSP - Free Report) shares soared 16.3% in the last trading session to close at $50.56.The move was backed by solid volume with far more shares changing ...
Crsp zacks score
Did you know?
WebMay 9, 2024 · CRISPR Therapeutics AG (CRSP) came out with a quarterly loss of $2.32 per share versus the Zacks Consensus Estimate of a loss of $1.91. This compares to loss of $1.51 per share a year ago. These ... WebFeb 21, 2024 · CRISPR Therapeutics AG (CRSP) came out with a quarterly loss of $1.41 per share versus the Zacks Consensus Estimate of a loss of $2.32. This compares to loss of $1.84 per share a year ago.
Web21 hours ago · Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers. ... Zacks News for CRSP ... WebMay 1, 2008 · CRSP provides the following data files: common stocks on the NYSE, AMEX and NASDAQ; CRSP Indexes; NASDAQ and S&P 500 composite indexes; Total Return …
WebApr 12, 2024 · Zacks Rank & Stocks to Consider. Currently, Panbela has a Zacks Rank #3 (Hold). Some better-ranked stocks for investors interested in the same sector are CRISPR Therapeutics (CRSP Quick Quote CRSP ... WebCRISPR Therapeutics AG (CRSP) $115.80 (As of 06/01/21) Price Target (6-12 Months): $122.00 Long Term:€6-12 Months Zacks Recommendation: (Since: 04/01/21) Neutral € …
WebSep 17, 2024 · The stock is currently a #3 (Hold) on the Zacks Rank. Four analysts revised their earnings estimate upwards in the last 60 days for fiscal 2024. The Zacks …
WebCRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to … stories behind the great hymnsWebApr 12, 2024 · Since there are currently no approved drug therapies for the treatment of FAP, Flynpovi has become a potentially life-changing therapeutic option for patients … stories behind the stars appWebApr 14, 2024 · CRISPR Therapeutics AG ( CRSP Quick Quote CRSP - Free Report) shares soared 16.3% in the last trading session to close at $50.56. The move was backed by … rose tree eye careWebApr 6, 2024 · According to the issued ratings of 18 analysts in the last year, the consensus rating for CRISPR Therapeutics stock is Hold based on the current 1 sell rating, 8 hold ratings and 9 buy ratings for CRSP. The average twelve-month price prediction for CRISPR Therapeutics is $72.89 with a high price target of $123.00 and a low price target of $39.00. rose tree dress shop wvWebApr 9, 2024 · 3/16/2024 - Zacks Investment Research. 21,440 Shares in CRISPR Therapeutics AG (NASDAQ:CRSP) Acquired by Continental Investors Services Inc. 3/16/2024 - Zolmax. CRISPR Therapeutics AG (CRSP) Stock Moves -0.51%: What You Should Know. 3/15/2024 - Zacks Investment Research. stories behind inventionsWebCRISPR Therapeutics AG (CRSP) $121.63 (As of 04/06/21) Price Target (6-12 Months): $128.00 Long Term:€6-12 Months Zacks Recommendation: (Since: 04/01/21) Neutral € … rose tree hill beddingWeb21 hours ago · Price To Cash Flow is a widely used stock evaluation measure. Find the latest Price To Cash Flow for CRISPR Therapeutics (CRSP) rose tree inn media pa